Biotech stocks hold steady in stormy week

Biotech indices were essentially flat on the week as investors digested news that included warnings to the labels of some new and existing drugs, as well as questions about the business practices of Valeant Pharmaceuticals International Inc. (TSX:VRX; NYSE:VRX). ...